Synthesis and 5-HT-3 receptor binding activity of 5-[125I]iodo-2,3-dimethoxy-N-(1-azabicyclo[2.2.2]oct-3-yl)benzamide and its 5-halogen-2-alkoxyl homologues
-
Add time:07/13/2019 Source:sciencedirect.com
Summary(S)-5-Iodo-2,3-dimethoxy-N-(1-azabicyclo[2.2.2]oct-3-yl)benzamide (MIZAC) was prepared from 5-iodo-2,3-dimethoxybenzoyl chloride and (S)-3-aminoquinuclidine. [125I]Iodode-stannylation of its corresponding 5-tri-n-butyltin derivative gave [125I]-MIZAC at 1800 Ci/mmol. Binding of [125I]-MIZAC in rat entorhinal cortex revealed a KD of 1.37 ± 0.21 nM. A series of racemic 2-O-alkyl derivatives of MIZAC were prepared and 5-HT-3 receptor affinities were determined by inhibition of [125I]-MIZAC binding. Optimal affinity for the receptor was obtained with small, electron-withdrawing substituents in the aromatic 5-position and with bulky substituents in the 3-position. [125I]-MIZAC is a selective radioligand useful for in vitro identification of the 5-HT-3 receptor.
We also recommend Trading Suppliers and Manufacturers of N-(2-Bromo-2-propenyl)benzamide (cas 102586-01-6). Pls Click Website Link as below: cas 102586-01-6 suppliers
Prev:Novel biodegradable copolyamides based on adipic acid, bis(p-aminocyclohexyl)methane and several α-amino acids: synthesis, characterization and study of their degradability for food packaging applications: 4
Next:4-Substituted 5-nitroisoquinolin-1-ones from intramolecular Pd-catalysed reaction of N-(2-alkenyl)-2-halo-3-nitrobenzamides) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Characterization of a novel iodinated sigma-2 receptor ligand as a cell proliferation marker07/17/2019
- Anti-HIV activity of N-(2,3-dihalogenopropyl)- and N-allyl-glycine containing pentapeptides.07/16/2019
- Synthesis and 5-HT-3 Receptor Binding of 2- and 3-(Halo)alkoxyl Substituted (S)-N-(1-Azabicyclo [2.2.2]oct-3-yl)-5-chlorobenzamides as Potential Radioligands07/15/2019
- 4-Substituted 5-nitroisoquinolin-1-ones from intramolecular Pd-catalysed reaction of N-(2-alkenyl)-2-halo-3-nitrobenzamides07/14/2019


